Octreotide Acetate Powder ≥99.5% CAS No: 83150-76-9
Octreotide Acetate Powder ≥99.5% CAS No: 83150-76-9
Octreotide Acetate Powder ≥99.5% ,Octreotide Acetate Powder,CAS No: 83150-76-9,Octreotide Acetate Powder CAS No: 83150-76-9
Product Name: Octreotide Acetate API Powder
product purity≥99.5%
CAS No: 83150-76-9
Send Inquiry
Description
Certified R&D Reagent
Octreotide Acetate
High-Purity Somatostatin Analogue (SSTR2/SSTR5 Selective Agonist)
Technical Specifications
CAS Number83150-76-9
Purity (HPLC)≥99.5%
Endotoxin<5 EU/mg
Moisture<5.0%
FormulaC₄₉H₆₆N₁₀O₁₀S₂ (Free base)
Mol. Weight1019.24
Storage2-8°C (Refrigerated)
Batch ControlFull COA Provided
Product Overview
Shaanxi Sunrise Pharmaceutical provides research-grade Octreotide Acetate, a synthetic octapeptide analogue of somatostatin. Our production process utilizes advanced lyophilization technology to ensure maximum peptide stability and solubility for delicate in vitro assays and drug delivery system research.
Receptor Selectivity Profile
In laboratory research models, Octreotide Acetate demonstrates a significantly higher binding affinity for SSTR2 and SSTR5 compared to natural somatostatin, making it a pivotal tool for endocrine signaling research.
| Receptor Subtype | Binding Affinity (IC₅₀, nM) | Research Application |
|---|---|---|
| SSTR2 | 0.1 - 0.5 (Strong) | GH & Glucagon inhibition research |
| SSTR5 | 5.0 - 7.0 (High) | Insulin secretion modulation models |
| SSTR3 | 25 - 35 (Moderate) | Cell proliferation assays |
| SSTR1 / SSTR4 | >1000 (Very Low) | Negative control study |
R&D Application Scenarios
Tumor Biology Research
Utilized in neuroendocrine tumor (NET) cell lines to study antiproliferative signaling pathways.
Formulation Development
Used as a model peptide for developing microsphere or hydrogel sustained-release systems.